fbpx
QQQ
+ 1.31
323.10
+ 0.4%
DIA
-0.86
344.51
-0.25%
SPY
-0.40
415.92
-0.1%
TLT
-0.61
137.40
-0.45%
GLD
-0.09
174.79
-0.05%

Aphria Stock Plunges On Cannabis Company's Q3 Results Ahead Of Tilray Merger

April 12, 2021 10:46 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Aphria Stock Plunges On Cannabis Company's Q3 Results Ahead Of Tilray Merger

Aphria Inc. (TSX:APHA) (NASDAQ:APHA), a cannabis consumer packaged goods company, posted financial results Monday for the third quarter and nine months ended Feb. 28. 

Aphria generated CA$153.6 million ($122.5 million) in net third-quarter revenue. That's a year-over-year increase of 6.4% and a sequential decline of 4.3%.

Net cannabis revenue amounted to CA$51.7 million, dropping by 7.8% year-over-year and 23.8% sequentially.

The Leamington, Ontario-based company reported an adjusted EBITDA gain of CA$12.7 million in the third quarter of 2021, representing the eighth consecutive quarter of positive EBITDA. Adjusted EBITDA from the cannabis business amounted to CA$7.9 million versus CA$12.9 million in the second quarter. 

Gross profit was CA$31.7 million, up year-over-year from CA$59.6 million.

See also: How to Buy Aphria Inc. (APHA) Stock

The company ended the quarter with CA$267.1 million in cash and cash equivalents.

Operating expenses increased by 21% quarter-over-quarter and roughly 96% year-over-year to CA$100 million.

The net loss in the third quarter was CA$361 million, or a CA$1.14 loss per share.

"The duration and impact of lockdowns across many of the regions we operate in, particularly in Canada, were greater than we initially anticipated for the cannabis industry and our business; however, we believe Aphria remains well-positioned with our leading brands and market share to experience a robust increase in our top-line as the market improves," Irwin Simon, the company's chairman and CEO, said in a statement. 

The Tilray Merger: In December, Aphria kicked off negotiations to merge with Tilray Inc. (NASDAQ:TLRY).

The combined company would continue to operate under the Tilray name with Simon as CEO.

The two companies have reached a definitive agreement to combine.

"We expect Aphria and Tilray's complementary cultures of innovation, brand development, and cultivation to further set us apart from others in the industry along with the strength of our balance sheet and cash availability as we enhance value for all stakeholders" Simon said. 

APHA Price Action: Aphria shares were trading down 14.31% at $13.95 at last check Monday. 

Photo by Esteban Lopez on Unsplash


Related Articles

Tilray Stock Is Getting Squeezed Between 2 Key Levels

Tilray Inc. (NASDAQ: TLRY) shares were trading higher Friday after a Jefferies analyst double upgraded the stock. The stock was double upgraded from Underperform to Buy and the price target was raised from $4.77 to $23. read more

High Tide Expands US Reach With 80% Stake In FABCBD

The retail-focused cannabis company High Tide Inc. (TSXV: HITI) (OTCQB: HITIF) (FRA: 2LY) said Monday that it will acquire 80% of Fab Nutrition, LLC. (operating as FABCBD) for $20.64 million in stock and cash. read more

Video: Tilray CEO Discusses Aphria Merger, US Market Ambitions, Cannabis As A CPG Business, And More

On Monday, the cannabis industry witnessed the creation of the world's largest cannabis company measured by revenue, as two Canadian giants, Tilray Inc. (NASDAQ: TLRY) and Aphria Inc. read more

Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week

Cannabis Countdown: Top 10 Marijuana and Psychedelics Industry News Stories of the Week read more